PK BIOTECH ApS Financials, key figures and credit report
Gross profit 23 841.9 kDKK FY 2025 -44.8% vs 2024
EBIT -70 124.7 kDKK FY 2025 -229.8% vs 2024
Net debt 194 487.8 kDKK FY 2025 +41.8% vs 2024
Quick ratio 0.2 FY 2025 +0 vs 2024
Income statement (kDKK)
2024 | 2025 | |
|---|---|---|
| Fiscal period length | 12 | 12 |
| Net sales | ||
| Gross profit | 43 160.00 | 23 841.93 |
| Employee benefit expenses | -45 095.00 | -39 157.83 |
| Other operating expenses | - 103.00 | -1 286.19 |
| Total depreciation | -19 223.00 | -53 522.60 |
| EBIT | -21 261.00 | -70 124.69 |
| Other financial income | 40.00 | 44.43 |
| Other financial expenses | -7 117.00 | -13 781.62 |
| Pre-tax profit | -28 338.00 | -83 861.88 |
| Income taxes | 5 994.00 | 13 077.08 |
| Net earnings | -22 344.00 | -70 784.80 |
Assets (kDKK)
2024 | 2025 | |
|---|---|---|
| Development expenditure | 14 812.00 | 7 115.51 |
| Intangible assets total | 14 812.00 | 7 115.51 |
| Land and waters | 73 631.00 | 66 754.65 |
| Buildings | 120 290.00 | 104 183.37 |
| Machinery and equipment | 32 984.00 | 8 993.39 |
| Advance payments and construction in progress | 5 006.87 | |
| Tangible assets total | 226 905.00 | 184 938.27 |
| Investments total | ||
| Non-current other receivables | 432.00 | |
| Long term receivables total | 432.00 | |
| Semifinished products | 17 619.00 | 14 216.10 |
| Raw materials and consumables | 4 470.00 | 4 003.69 |
| Finished products/goods | 30 408.00 | 20 879.86 |
| Inventories total | 52 497.00 | 39 099.66 |
| Current trade debtors | 15 285.00 | 12 819.17 |
| Current amounts owed by group member comp. | 3 680.00 | 29 516.76 |
| Prepayments and accrued income | 3 311.00 | 2 102.52 |
| Current other receivables | 850.00 | 1 216.47 |
| Current deferred tax assets | 3 029.00 | |
| Short term receivables total | 26 155.00 | 45 654.91 |
| Cash and bank deposits | 1 082.00 | 542.60 |
| Cash and cash equivalents | 1 082.00 | 542.60 |
| Balance sheet total (assets) | 321 451.00 | 277 782.95 |
Equity and liabilities (kDKK)
2023 | 2024 | 2025 | |
|---|---|---|---|
| Share capital | 129 733.00 | 2 500.00 | 2 500.00 |
| Asset revaluation reserve | 15 184.00 | 10 112.33 | |
| Other reserves | 10 057.00 | 5 550.10 | |
| Retained earnings | 101 821.00 | 85 436.90 | |
| Profit of the financial year | -22 344.00 | -70 784.80 | |
| Shareholders equity total | 129 733.00 | 107 218.00 | 32 814.52 |
| Provisions | 17 228.00 | ||
| Non-current loans from credit institutions | 9 417.00 | ||
| Non-current liabilities total | 9 417.00 | ||
| Current loans from credit institutions | 110 365.00 | 0.51 | |
| Current trade creditors | 18 827.00 | 12 813.25 | |
| Current owed to group member | 18 478.00 | 195 029.88 | |
| Other non-interest bearing current liabilities | 37 893.00 | 37 124.80 | |
| Accruals and deferred income | 2 025.00 | ||
| Current liabilities total | 187 588.00 | 244 968.43 | |
| Balance sheet total (liabilities) | 129 733.00 | 321 451.00 | 277 782.95 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated